Login to Your Account

Arena Builds Pharma Muscle in Expanded Belviq Deal with Eisai

By Jennifer Boggs
Managing Editor

Friday, November 8, 2013
Shares of Arena Pharmaceuticals Inc. jumped 17.4 percent Friday on news of an expanded alliance with Eisai Inc. for obesity drug Belviq (lorcaserin), a deal that brings $60 million up front and aims to advance the drug into new commercial markets and possibly new indications.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription